About
RenovoRx develops targeted oncology therapies and commercializes the RenovoCath, an FDA-cleared drug-delivery device designed for intra-arterial chemotherapy administration, currently conducting Phase III trials for treating locally advanced pancreatic cancer.
Explore RenovoRx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.